Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12607000527460
Ethics application status
Approved
Date submitted
4/10/2007
Date registered
12/10/2007
Date last updated
12/08/2016
Type of registration
Prospectively registered
Titles & IDs
Public title
Droperidol OR Midazolam (DORM) for sedation in patients with psychostimulant induced agitation
Query!
Scientific title
A randomised controlled trial of intramuscular droperidol versus intramuscular midazolam for rapid sedation of aggressive and agitated psychostimulant-associated delirium
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
DORM
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Psychostimulant induced agitation and delirium
2429
0
Query!
Condition category
Condition code
Injuries and Accidents
2531
2531
0
0
Query!
Poisoning
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Intramuscular droperidol, single 10mg dose
Query!
Intervention code [1]
2149
0
Treatment: Drugs
Query!
Comparator / control treatment
1) Intramuscular midazolam, single 10mg dose and 2) intramuscular droperidol, single 5mg dose with intramuscular midazolam, single 5mg dose
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
3430
0
Time until "all clear" by the security staff [ie. patient is safely restrained and sedated] to estimate onset of sedation
Query!
Assessment method [1]
3430
0
Query!
Timepoint [1]
3430
0
Outcome is a measure of time which commences at the time of intramuscular administration of treatment or comparator drugs
Query!
Primary outcome [2]
3431
0
Time until the next dose of parenteral medication for sedation to estimate duration of sedation
Query!
Assessment method [2]
3431
0
Query!
Timepoint [2]
3431
0
Outcome is a measure of time
Query!
Secondary outcome [1]
5698
0
Reduction in a 6-point agitation scale (6=highly aroused and violent, 0=asleep)
Query!
Assessment method [1]
5698
0
Query!
Timepoint [1]
5698
0
From baseline to 20 minutes after trial medication
Query!
Secondary outcome [2]
5699
0
Reduction in the altered mental status scale
Query!
Assessment method [2]
5699
0
Query!
Timepoint [2]
5699
0
From baseline to 20 minutes after trial medication
Query!
Secondary outcome [3]
5700
0
Injuries to the patient or staff members
Query!
Assessment method [3]
5700
0
Query!
Timepoint [3]
5700
0
During Emergency Department [ED] admission
Query!
Secondary outcome [4]
5701
0
Requirement for further parenteral sedation
Query!
Assessment method [4]
5701
0
Query!
Timepoint [4]
5701
0
During Emergency Department [ED] admission
Query!
Secondary outcome [5]
5702
0
Total oral sedation required
Query!
Assessment method [5]
5702
0
Query!
Timepoint [5]
5702
0
During Emergency Department [ED]admission
Query!
Secondary outcome [6]
5703
0
Further calls for security staff to the patient
Query!
Assessment method [6]
5703
0
Query!
Timepoint [6]
5703
0
During Emergency Department [ED] admission
Query!
Eligibility
Key inclusion criteria
Emergency department patients with suspected or confirmed severe agitated delirium/psychosis or aggression due to psychostimulant toxicity; AND require intervention by hospital security staff or physical restraint
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
Not stated
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1. Patients with acute psychosis clearly due to other causes;
2. Patient who are willing to take oral or intravenous medication for sedation without physical restraint;
3. Patients under the age of 18 years of age;
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
All patients presenting to the ED meeting the inclusion criteria will be enrolled. Patient consent will be waived due to the treatment being administered based on a Duty of Care. Enrolled patients will then be blindly allocated to one of three treatment arms. Identical treatment kits (containers) containing the 3 different treatments will be numbered sequentially which will only be used by the treating doctors once the patient has been recruited. There is no way that the treating doctor or research assistant will be aware of the allocation because all of the treatment kits will be identical and number for sequential use, so they will not know what is in the treatment kit even if they look at it.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Treatment kits will be randomised in blocks and numbered sequentially.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
There will be three parallel arms:
1. 10mg droperidol (2 x 5mg droperidol in 2mL)
2. 10mg midazolam (2 x 5mg midazolam in 2mL)
3. 5mg droperidol + 5mg midazolam (5mg droperidol in 2mL + 5mg midazolam in 2mL)
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
1/01/2008
Query!
Actual
27/08/2008
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
25/07/2009
Query!
Date of last data collection
Anticipated
Query!
Actual
26/07/2009
Query!
Sample size
Target
120
Query!
Accrual to date
Query!
Final
91
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Recruitment postcode(s) [1]
451
0
2298
Query!
Funding & Sponsors
Funding source category [1]
2680
0
Hospital
Query!
Name [1]
2680
0
NSW Health Drug and Alcohol
Query!
Address [1]
2680
0
Research and Health System Development
Mental Health and Drug and Alcohol Office
NSW Health Locked Mail Bag 961
North Sydney NSW 2060
Query!
Country [1]
2680
0
Australia
Query!
Primary sponsor type
Individual
Query!
Name
Geoffrey Isbister
Query!
Address
Department of Clinical Toxicology and Pharmacology
Calvary Mater Hospital, Newcastle
Edith St Waratah NSW 2298
Query!
Country
Australia
Query!
Secondary sponsor category [1]
2421
0
None
Query!
Name [1]
2421
0
Query!
Address [1]
2421
0
Query!
Country [1]
2421
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
4599
0
Hunter New England Area Human Research Ethics Committee
Query!
Ethics committee address [1]
4599
0
Locked Bag 1
New Lambton NSW 2305
Query!
Ethics committee country [1]
4599
0
Query!
Date submitted for ethics approval [1]
4599
0
28/09/2007
Query!
Approval date [1]
4599
0
Query!
Ethics approval number [1]
4599
0
Query!
Ethics committee name [2]
295729
0
Hunter and New England HREC
Query!
Ethics committee address [2]
295729
0
Newcastle
Query!
Ethics committee country [2]
295729
0
Australia
Query!
Date submitted for ethics approval [2]
295729
0
30/06/2007
Query!
Approval date [2]
295729
0
02/11/2007
Query!
Ethics approval number [2]
295729
0
7/10/24/3.05
Query!
Summary
Brief summary
Aggressive behaviour related to psychostimulant abuse, poisoning and/or withdrawal, such as amphetamines, is an increasing problem in emergency departments. It can lead to patient harm, injury to staff and damage to hospital property if the situation is not rapidly controlled. Intravenous sedation can be difficult, particularly in smaller urban and regional hospitals because it requires sufficient staff numbers to restrain the patient to obtain intravenous access and can lead to needle-stick injuries. Intramuscular sedation with benzodiazepines, mainly midazolam, is unpredictable and can lead to over-sedating the patient or not sedating them enough, and may be associated with problems in this group due to benzodiazepine tolerance. Droperidol is a highly sedative antipsychotic medication that is rarely associated with complications. This study aims to compare the effectiveness of intramuscular droperidol and intramuscular benzodiazepines for sedation of aggressive patients with psychostimulant associated agitation in a randomised controlled trial. The study is designed to assess both the speed of onset and duration of sedation.
Query!
Trial website
Nil
Query!
Trial related presentations / publications
Nil
Query!
Public notes
Query!
Contacts
Principal investigator
Name
28092
0
Prof Geoffrey Isbister
Query!
Address
28092
0
Calvary Mater Newcastle
Waratah NSW 2298
Query!
Country
28092
0
Australia
Query!
Phone
28092
0
0438466471
Query!
Fax
28092
0
Query!
Email
28092
0
[email protected]
Query!
Contact person for public queries
Name
11249
0
Prof Geoff Isbister
Query!
Address
11249
0
Department of Clinical Toxicology and Pharmacology
Calvary Mater Hospital, Newcastle
Edith St Waratah NSW 2298
Query!
Country
11249
0
Australia
Query!
Phone
11249
0
612 49211211
Query!
Fax
11249
0
612 94754893
Query!
Email
11249
0
[email protected]
Query!
Contact person for scientific queries
Name
2177
0
Prof Geoff Isbister
Query!
Address
2177
0
Department of Clinical Toxicology and Pharmacology
Calvary Mater Hospital, Newcastle
Edith St Waratah NSW 2298
Query!
Country
2177
0
Australia
Query!
Phone
2177
0
612 49211211
Query!
Fax
2177
0
612 94754893
Query!
Email
2177
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
Population pharmacokinetics of intramuscular droperidol in acutely agitated patients.
2016
https://dx.doi.org/10.1111/bcp.13093
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF